Ibritumomab tiuxetan (Zevalin) and elevated serum human anti-murine antibody (HAMA)
Ibritumomab Tiuxetan (Zevalin) is an anti CD-20 murine monoclonal antibody linked to the radio-isotope 90-yttrium (90Y) by the chelator Tiuxetan. It is FDA approved for treatment of relapsed low grade or follicular B-cell Non-Hodgkin’s Lymphoma (NHL) or newly diagnosed follicular NHL following an in...
Furkejuvvon:
| Váldodahkkit: | , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Wolters Kluwer Medknow Publications
2018-07-01
|
| Ráidu: | Hematology/Oncology and Stem Cell Therapy |
| Fáttát: | |
| Liŋkkat: | https://journals.lww.com/10.1016/j.hemonc.2017.12.004 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|